{"organizations": [], "uuid": "a36eaf40b2dea7c27358c5d0c7a9a0736aa680d3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-us-patent-and-trademark-office-awa/brief-u-s-patent-and-trademark-office-awards-biopharmx-patent-protection-idUSFWN1R20NN", "country": "US", "domain_rank": 408, "title": "BRIEF-U.S. Patent And Trademark Office Awards Biopharmx Patent Protection For Novel Tetracycline-Class Topical Drug Compositions", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-20T15:37:00.000+02:00", "replies_count": 0, "uuid": "a36eaf40b2dea7c27358c5d0c7a9a0736aa680d3"}, "author": "", "url": "https://www.reuters.com/article/brief-us-patent-and-trademark-office-awa/brief-u-s-patent-and-trademark-office-awards-biopharmx-patent-protection-idUSFWN1R20NN", "ord_in_thread": 0, "title": "BRIEF-U.S. Patent And Trademark Office Awards Biopharmx Patent Protection For Novel Tetracycline-Class Topical Drug Compositions", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "biopharmx corp", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "patent protection for novel tetracycline-class topical drug compositions reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 20, 2018 / 1:36 PM / Updated 6 minutes ago BRIEF-U.S. Patent And Trademark Office Awards Biopharmx Patent Protection For Novel Tetracycline-Class Topical Drug Compositions Reuters Staff March 20 (Reuters) - Biopharmx Corp: * U.S. PATENT AND TRADEMARK OFFICE AWARDS BIOPHARMX PATENT PROTECTION FOR NOVEL TETRACYCLINE-CLASS TOPICAL DRUG COMPOSITIONS * BIOPHARMX CORP - ‍PATENT PROTECTS A NEW CATEGORY OF INNOVATIVE DRUG DELIVERY SYSTEMS​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-20T15:37:00.000+02:00", "crawled": "2018-03-20T15:48:11.001+02:00", "highlightTitle": ""}